VISTAGEN THERAPEUTICS, INC

Organization

BURLINGAME, CA, US

Ticker Symbols

NASDAQ:VTGN

PHARMACEUTICAL PREPARATIONS
Business Address
343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Mailing Address
343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
State Location
CA
State of Incorporation
NV

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Synthesis of 4-chlorokynurenines and intermediates
- Patent number 11,427,530
- Issue date Aug 30, 2022
- Vistagen Therapeutics, Inc.
- Daniel Levin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dosage forms and therapeutic uses of L-4-chlorokynurenine
- Patent number 10,980,758
- Issue date Apr 20, 2021
- Vistagen Therapeutics, Inc.
- H. Ralph Snodgrass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage forms and therapeutic uses of L-4-chlorokynurenine
- Patent number 10,821,089
- Issue date Nov 3, 2020
- Vistagen Therapeutics, Inc.
- H. Ralph Snodgrass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage forms and therapeutic uses of L-4-chlorokynurenine
- Patent number 10,632,091
- Issue date Apr 28, 2020
- Vistagen Therapeutics, Inc.
- H. Ralph Snodgrass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage forms and therapeutic uses of L-4-chlorokynurenine
- Patent number 10,617,663
- Issue date Apr 14, 2020
- Vistagen Therapeutics, Inc.
- H. Ralph Snodgrass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the synthesis of chiral kynurenine compounds
- Patent number 10,294,502
- Issue date May 21, 2019
- Vistagen Therapeutics, Inc.
- Stefan Abele
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dosage forms and therapeutic uses of L-4-chlorokynurenine
- Patent number 9,993,450
- Issue date Jun 12, 2018
- Vistagen Therapeutics, Inc.
- H. Ralph Snodgrass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage forms and therapeutic uses L-4-chlorokynurenine
- Patent number 9,993,453
- Issue date Jun 12, 2018
- Vistagen Therapeutics, Inc.
- H. Ralph Snodgrass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the synthesis of chiral kynurenine compounds
- Patent number 9,834,801
- Issue date Dec 5, 2017
- Vistagen Therapeutics, Inc.
- Stefan Abele
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Toxicity typing using liver stem cells
- Patent number 8,512,957
- Issue date Aug 20, 2013
- Vistagen Therapeutics, Inc.
- H. Ralph Snodgrass
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
- Publication number 20240122887
- Publication date Apr 18, 2024
- VistaGen Therapeutics, Inc.
- H. Ralph SNODGRASS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF ADJUSTMENT DISORDERS
- Publication number 20230210867
- Publication date Jul 6, 2023
- VistaGen Therapeutics, Inc.
- Shawn K. SINGH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETIC VARIANTS ASSOCIATED WITH RESPONSE TO TREATMENT OF NEUROLOGI...
- Publication number 20220202756
- Publication date Jun 30, 2022
- VistaGen Therapeutics, Inc.
- Ralph H. SNODGRASS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHESIS OF 4-CHLOROKYNURENINES AND INTERMEDIATES
- Publication number 20210276942
- Publication date Sep 9, 2021
- VistaGen Therapeutics, Inc.
- Daniel LEVIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
- Publication number 20190321317
- Publication date Oct 24, 2019
- VistaGen Therapeutics, Inc.
- H. Ralph SNODGRASS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
- Publication number 20190125707
- Publication date May 2, 2019
- VistaGen Therapeutics, Inc.
- H. Ralph SNODGRASS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS
- Publication number 20180171372
- Publication date Jun 21, 2018
- VistaGen Therapeutics, Inc.
- Stefan ABELE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
- Publication number 20180140568
- Publication date May 24, 2018
- VistaGen Therapeutics, Inc.
- H. Ralph SNODGRASS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE FORMS AND THERAPEUTIC USES L-4-CHLOROKYNURENINE
- Publication number 20160158178
- Publication date Jun 9, 2016
- VistaGen Therapeutics, Inc.
- H. Ralph SNODGRASS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS AND INTERMEDIATES
- Publication number 20160031800
- Publication date Feb 4, 2016
- VistaGen Therapeutics, Inc.
- Alexander TRETYAKOV
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR THE SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS
- Publication number 20160032334
- Publication date Feb 4, 2016
- VistaGen Therapeutics, Inc.
- Stefan ABELE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
- Publication number 20150359772
- Publication date Dec 17, 2015
- VistaGen Therapeutics, Inc.
- H. Ralph SNODGRASS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOXICITY TYPING USING LIVER STEM CELLS
- Publication number 20120220469
- Publication date Aug 30, 2012
- VistaGen Therapeutics, Inc.
- H. Ralph SNODGRASS
- G01 - MEASURING TESTING

Trademarklast 30 trademarks

Information Trademark
90535780 - VISTAGEN
- Serial number 90535780
- Filing date Feb 19, 2021
- VistaGen Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76146181 - VISTAGEN
- Serial number 76146181
- Registration number 2787886
- Filing date Oct 13, 2000
- VistaGen, Inc.
- 42 - Scientific and technological services and research and design relating thereto

VISTAGEN THERAPEUTICS, INC

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Synthesis of 4-chlorokynurenines and intermediates

Dosage forms and therapeutic uses of L-4-chlorokynurenine

Dosage forms and therapeutic uses of L-4-chlorokynurenine

Dosage forms and therapeutic uses of L-4-chlorokynurenine

Dosage forms and therapeutic uses of L-4-chlorokynurenine

Methods for the synthesis of chiral kynurenine compounds

Dosage forms and therapeutic uses of L-4-chlorokynurenine

Dosage forms and therapeutic uses L-4-chlorokynurenine

Methods for the synthesis of chiral kynurenine compounds

Toxicity typing using liver stem cells

Patents Applicationslast 30 patents

THERAPEUTIC USES OF L-4-CHLOROKYNURENINE

TREATMENT OF ADJUSTMENT DISORDERS

GENETIC VARIANTS ASSOCIATED WITH RESPONSE TO TREATMENT OF NEUROLOGI...

SYNTHESIS OF 4-CHLOROKYNURENINES AND INTERMEDIATES

THERAPEUTIC USES OF L-4-CHLOROKYNURENINE

DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE

METHODS FOR THE SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS

THERAPEUTIC USES OF L-4-CHLOROKYNURENINE

DOSAGE FORMS AND THERAPEUTIC USES L-4-CHLOROKYNURENINE

SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS AND INTERMEDIATES

METHODS FOR THE SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS

DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE

TOXICITY TYPING USING LIVER STEM CELLS

Trademarklast 30 trademarks

90535780 - VISTAGEN

76146181 - VISTAGEN